Seeing Is Believing

Currently out of the existing stock ratings of David Buck, 34 are a BUY (77.27%), 10 are a HOLD (22.73%).
Analyst David Buck, carries an average stock price target met ratio of 46.79% that have a potential upside of 26.36% achieved within 275 days. Previously, David Buck worked at B. RILEY, NORTHLAND CAPITAL MARKETS.
David Buck’s has documented 87 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CORT, Corcept Therapeutics at 05-Feb-2019.
Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for ENDP (ENDO INTERNATIONAL PLC) at 8/7/2018. The price target of $15 was fulfilled within 1 day with a profit of $2.35 (18.58%) receiving and performance score of 185.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$337
$91.2 (37.10%)
$307
Buy Since 06-Mar-2025
$322
$76.2 (31.00%)
$283
21 days ago
(25-Aug-2026)
11/14 (78.57%)
$72.71 (29.17%)
668
Buy Since 14-Jul-2025
$300
$54.2 (22.05%)
$210
21 days ago
(25-Aug-2026)
3/4 (75%)
$50.71 (20.34%)
113
Buy Since 01-Mar-2022
$281
$35.2 (14.32%)
$264
21 days ago
(25-Aug-2026)
15/17 (88.24%)
$31.71 (12.72%)
663
Buy Since 01-Jan-2018
$310
$64.2 (26.12%)
$292
21 days ago
(25-Aug-2026)
36/39 (92.31%)
$60.71 (24.35%)
831